Indeed Snapshot

Track Concert Pharmaceuticals reviews on Indeed to uncover insights on employee sentiment

Rows

Open dataset
Ticker Symbol Entity Name As Of Date Profile Url Name Website Industry Description Revenue Headquarters location CEO Rating: CEO (%) Rating: CEO Responses Count Rating: Overall Happiness: Compensation score Happiness: Support score Happiness: Purpose score Happiness: Flexibility score Happiness: Energy score Happiness: Work Happiness score Happiness: Trust score Happiness: Learning score Happiness: Belonging score Happiness: Inclusion score Happiness: Overall score Happiness: Appreciation score Happiness: Achievement score Happiness: Responses Count Review Count Ratings Responses Count Rating: Culture & Values Rating: Compensation & Benefits Rating: Job Security & Advancement Rating: Senior Management Rating: Worklife Balance Interview: Duration Responses count Interview Duration Interview: Difficulty Responses count Interview Difficulty Interview: Experience Responses count Interview Experience Work Culture: Stressful (0) to Relaxed (1) Ratio Work Culture: Slow Paced (0) to Fast Paced (1) Ratio Work Culture: Competitive (0) to Collaborative (1) Ratio Date Added Date Updated Company Name Sector Industry
nasdaq:cnce https://www.indeed.com/cmp/concert-pharmaceuticals,-inc. Aug 29th, 2022 12:00AM Open Concert Pharmaceuticals, Inc. Biotechnology At Concert Pharmaceuticals, we are pioneering the use of deuterium chemistry to discover and develop innovative new medicines that positively impact patient care and address important medical needs. Our innovative approach has already resulted in multiple drug candidates that are progressing in clinical development. Each of these novel candidates is a result of improving a drug using our deuterium chemistry, expanding the potential of a previously studied or approved drug. Our robust pipeline of new medicines is rapidly advancing to offer innovative ways to treat a broad range of disease areas, targeting autoimmune and inflammatory diseases and central nervous system (CNS) disorders. Our DCE Platform drives product innovation, enabling us to design drug candidates to create differentiated properties and address patient needs. Leveraging our team’s deep experience in drug development, we identify opportunities where deuterium chemistry can create drug candidates that address needs in important disease areas. RRv1_UNDER_1M Lexington, MA 5.00 3.00 Aug 29th, 2022 11:45AM Aug 29th, 2022 11:45AM Concert Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:cnce https://www.indeed.com/cmp/concert-pharmaceuticals,-inc. Aug 28th, 2022 12:00AM Open Concert Pharmaceuticals, Inc. Biotechnology At Concert Pharmaceuticals, we are pioneering the use of deuterium chemistry to discover and develop innovative new medicines that positively impact patient care and address important medical needs. Our innovative approach has already resulted in multiple drug candidates that are progressing in clinical development. Each of these novel candidates is a result of improving a drug using our deuterium chemistry, expanding the potential of a previously studied or approved drug. Our robust pipeline of new medicines is rapidly advancing to offer innovative ways to treat a broad range of disease areas, targeting autoimmune and inflammatory diseases and central nervous system (CNS) disorders. Our DCE Platform drives product innovation, enabling us to design drug candidates to create differentiated properties and address patient needs. Leveraging our team’s deep experience in drug development, we identify opportunities where deuterium chemistry can create drug candidates that address needs in important disease areas. RRv1_UNDER_1M Lexington, MA 5.00 3.00 Aug 28th, 2022 04:44AM Aug 28th, 2022 04:44AM Concert Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:cnce https://www.indeed.com/cmp/concert-pharmaceuticals,-inc. Aug 27th, 2022 12:00AM Open Concert Pharmaceuticals, Inc. Biotechnology At Concert Pharmaceuticals, we are pioneering the use of deuterium chemistry to discover and develop innovative new medicines that positively impact patient care and address important medical needs. Our innovative approach has already resulted in multiple drug candidates that are progressing in clinical development. Each of these novel candidates is a result of improving a drug using our deuterium chemistry, expanding the potential of a previously studied or approved drug. Our robust pipeline of new medicines is rapidly advancing to offer innovative ways to treat a broad range of disease areas, targeting autoimmune and inflammatory diseases and central nervous system (CNS) disorders. Our DCE Platform drives product innovation, enabling us to design drug candidates to create differentiated properties and address patient needs. Leveraging our team’s deep experience in drug development, we identify opportunities where deuterium chemistry can create drug candidates that address needs in important disease areas. RRv1_UNDER_1M Lexington, MA 5.00 3.00 Aug 27th, 2022 04:04AM Aug 27th, 2022 04:04AM Concert Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:cnce https://www.indeed.com/cmp/concert-pharmaceuticals,-inc. Aug 25th, 2022 12:00AM Open Concert Pharmaceuticals, Inc. Biotechnology At Concert Pharmaceuticals, we are pioneering the use of deuterium chemistry to discover and develop innovative new medicines that positively impact patient care and address important medical needs. Our innovative approach has already resulted in multiple drug candidates that are progressing in clinical development. Each of these novel candidates is a result of improving a drug using our deuterium chemistry, expanding the potential of a previously studied or approved drug. Our robust pipeline of new medicines is rapidly advancing to offer innovative ways to treat a broad range of disease areas, targeting autoimmune and inflammatory diseases and central nervous system (CNS) disorders. Our DCE Platform drives product innovation, enabling us to design drug candidates to create differentiated properties and address patient needs. Leveraging our team’s deep experience in drug development, we identify opportunities where deuterium chemistry can create drug candidates that address needs in important disease areas. RRv1_UNDER_1M Lexington, MA 5.00 3.00 Aug 25th, 2022 08:43AM Aug 25th, 2022 08:43AM Concert Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:cnce https://www.indeed.com/cmp/concert-pharmaceuticals,-inc. Aug 23rd, 2022 12:00AM Open Concert Pharmaceuticals, Inc. Biotechnology At Concert Pharmaceuticals, we are pioneering the use of deuterium chemistry to discover and develop innovative new medicines that positively impact patient care and address important medical needs. Our innovative approach has already resulted in multiple drug candidates that are progressing in clinical development. Each of these novel candidates is a result of improving a drug using our deuterium chemistry, expanding the potential of a previously studied or approved drug. Our robust pipeline of new medicines is rapidly advancing to offer innovative ways to treat a broad range of disease areas, targeting autoimmune and inflammatory diseases and central nervous system (CNS) disorders. Our DCE Platform drives product innovation, enabling us to design drug candidates to create differentiated properties and address patient needs. Leveraging our team’s deep experience in drug development, we identify opportunities where deuterium chemistry can create drug candidates that address needs in important disease areas. RRv1_UNDER_1M Lexington, MA 5.00 3.00 Aug 23rd, 2022 10:37AM Aug 23rd, 2022 10:37AM Concert Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:cnce https://www.indeed.com/cmp/concert-pharmaceuticals,-inc. Aug 21st, 2022 12:00AM Open Concert Pharmaceuticals, Inc. Biotechnology At Concert Pharmaceuticals, we are pioneering the use of deuterium chemistry to discover and develop innovative new medicines that positively impact patient care and address important medical needs. Our innovative approach has already resulted in multiple drug candidates that are progressing in clinical development. Each of these novel candidates is a result of improving a drug using our deuterium chemistry, expanding the potential of a previously studied or approved drug. Our robust pipeline of new medicines is rapidly advancing to offer innovative ways to treat a broad range of disease areas, targeting autoimmune and inflammatory diseases and central nervous system (CNS) disorders. Our DCE Platform drives product innovation, enabling us to design drug candidates to create differentiated properties and address patient needs. Leveraging our team’s deep experience in drug development, we identify opportunities where deuterium chemistry can create drug candidates that address needs in important disease areas. RRv1_UNDER_1M Lexington, MA 5.00 3.00 Aug 21st, 2022 12:20PM Aug 21st, 2022 12:20PM Concert Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:cnce https://www.indeed.com/cmp/concert-pharmaceuticals,-inc. Aug 20th, 2022 12:00AM Open Concert Pharmaceuticals, Inc. Biotechnology At Concert Pharmaceuticals, we are pioneering the use of deuterium chemistry to discover and develop innovative new medicines that positively impact patient care and address important medical needs. Our innovative approach has already resulted in multiple drug candidates that are progressing in clinical development. Each of these novel candidates is a result of improving a drug using our deuterium chemistry, expanding the potential of a previously studied or approved drug. Our robust pipeline of new medicines is rapidly advancing to offer innovative ways to treat a broad range of disease areas, targeting autoimmune and inflammatory diseases and central nervous system (CNS) disorders. Our DCE Platform drives product innovation, enabling us to design drug candidates to create differentiated properties and address patient needs. Leveraging our team’s deep experience in drug development, we identify opportunities where deuterium chemistry can create drug candidates that address needs in important disease areas. RRv1_UNDER_1M Lexington, MA 5.00 3.00 Aug 20th, 2022 01:57PM Aug 20th, 2022 01:57PM Concert Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:cnce https://www.indeed.com/cmp/concert-pharmaceuticals,-inc. Aug 19th, 2022 12:00AM Open Concert Pharmaceuticals, Inc. Biotechnology At Concert Pharmaceuticals, we are pioneering the use of deuterium chemistry to discover and develop innovative new medicines that positively impact patient care and address important medical needs. Our innovative approach has already resulted in multiple drug candidates that are progressing in clinical development. Each of these novel candidates is a result of improving a drug using our deuterium chemistry, expanding the potential of a previously studied or approved drug. Our robust pipeline of new medicines is rapidly advancing to offer innovative ways to treat a broad range of disease areas, targeting autoimmune and inflammatory diseases and central nervous system (CNS) disorders. Our DCE Platform drives product innovation, enabling us to design drug candidates to create differentiated properties and address patient needs. Leveraging our team’s deep experience in drug development, we identify opportunities where deuterium chemistry can create drug candidates that address needs in important disease areas. RRv1_UNDER_1M Lexington, MA 5.00 3.00 Aug 19th, 2022 12:20PM Aug 19th, 2022 12:20PM Concert Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:cnce https://www.indeed.com/cmp/concert-pharmaceuticals,-inc. Aug 18th, 2022 12:00AM Open Concert Pharmaceuticals, Inc. Biotechnology At Concert Pharmaceuticals, we are pioneering the use of deuterium chemistry to discover and develop innovative new medicines that positively impact patient care and address important medical needs. Our innovative approach has already resulted in multiple drug candidates that are progressing in clinical development. Each of these novel candidates is a result of improving a drug using our deuterium chemistry, expanding the potential of a previously studied or approved drug. Our robust pipeline of new medicines is rapidly advancing to offer innovative ways to treat a broad range of disease areas, targeting autoimmune and inflammatory diseases and central nervous system (CNS) disorders. Our DCE Platform drives product innovation, enabling us to design drug candidates to create differentiated properties and address patient needs. Leveraging our team’s deep experience in drug development, we identify opportunities where deuterium chemistry can create drug candidates that address needs in important disease areas. RRv1_UNDER_1M Lexington, MA 5.00 3.00 Aug 18th, 2022 04:04AM Aug 18th, 2022 04:04AM Concert Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:cnce https://www.indeed.com/cmp/concert-pharmaceuticals,-inc. Aug 17th, 2022 12:00AM Open Concert Pharmaceuticals, Inc. Biotechnology At Concert Pharmaceuticals, we are pioneering the use of deuterium chemistry to discover and develop innovative new medicines that positively impact patient care and address important medical needs. Our innovative approach has already resulted in multiple drug candidates that are progressing in clinical development. Each of these novel candidates is a result of improving a drug using our deuterium chemistry, expanding the potential of a previously studied or approved drug. Our robust pipeline of new medicines is rapidly advancing to offer innovative ways to treat a broad range of disease areas, targeting autoimmune and inflammatory diseases and central nervous system (CNS) disorders. Our DCE Platform drives product innovation, enabling us to design drug candidates to create differentiated properties and address patient needs. Leveraging our team’s deep experience in drug development, we identify opportunities where deuterium chemistry can create drug candidates that address needs in important disease areas. RRv1_UNDER_1M Lexington, MA 5.00 3.00 Aug 17th, 2022 09:43AM Aug 17th, 2022 09:43AM Concert Pharmaceuticals Health Care Pharmaceuticals & Biotechnology

Request a demo to view additional historical data, and much more.

Request Demo

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.